Fourth dose of BNT162b2 prevents severe COVID-19 in nursing home residents
Jun 27, 2022
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
Risk for breakthrough SARS-CoV-2 infection lower with mRNA-1273
Feb 02, 2022
The risk for breakthrough infection and of 60-day hospitalization was significantly lower for mRNA-1273 (Moderna) versus BNT162b2 (Pfizer-BioNTech) vaccination.
Breakthrough SARS-CoV-2 infections ID’d in fully vaccinated
Aug 02, 2021
39 infections documented in 1,497 health care workers; 19 percent had persistent symptoms despite most cases being mild, asymptomatic
COVID-19 vaccine booster dose cuts infection in those 60 and older
Sep 17, 2021
A large Israeli study shows a reduction in confirmed infection and severe illness among adults 60 years of age and older.
Vaccination protects against death from SARS-CoV-2 delta variant
Oct 28, 2021
A Scotland cohort study shows that vaccination effectiveness with the ChAdOx1 nCoV-19 (Astra Zeneca, not available in the U.S.) or BNT162b2 (Pfizer–BioNTech) vaccine was 90% and 87%, respectively, for...
Odds of SARS-CoV-2 infection down after third BNT162b2 dose
Dec 03, 2021
The estimated odds ratio of 0.14 at 28 to 65 days after receipt of the Pfizer-BioNTech booster was compared with those who received two doses.
For fully vaccinated, immunity against SARS-CoV-2 wanes over time
Oct 29, 2021
The researchers found that among persons aged 60 years or older, the rate of infection was higher for those fully vaccinated in January 2021 (when they were first eligible) versus those fully vaccinated...
Vaccination seems less protective against transmission of delta variant
Jan 07, 2022
The reduction in transmission of SARS-CoV-2 associated with COVID-19 vaccination was smaller for the delta variant versus the alpha variant.
Home care, get on board the vaccine mandate bus
By
Liza Berger
Jul 30, 2021
To require vaccinations or to not require vaccinations. That, to paraphrase William Shakespeare, is the question.
COVID-19 vaccines prevent hospitalizations in high-risk populations
Sep 16, 2021
Vaccine effectiveness was 81 to 95% for adults aged 85 years and older, those with chronic medical conditions, and Black or Hispanic adults.